
Osteoporosis is a condition in which bones lose density and strength, becoming porous and fragile. In osteoporosis, bone is broken down faster than it is replaced, causing bones to weaken over time.
Often called a "silent disease," bone loss occurs gradually without symptoms — most people are unaware until they experience a fracture. Fractures can occur with minimal force, such as a minor fall, and most commonly affect the spine, hip, and wrist.
Osteoporosis is closely related to osteopenia — lower-than-normal bone density that has not yet reached the osteoporosis threshold. Osteopenia does not always progress to osteoporosis but is an important early warning sign.
Over one million Australians are living with osteoporosis, with a further 6.3 million living with osteopenia. It affects one in three women and one in five men over 50.
While most commonly associated with post-menopausal women — oestrogen plays a key role in maintaining bone density — osteoporosis also affects men and can occur at younger ages in people with certain risk factors. It is responsible for approximately 183,000 fractures in Australia each year, many causing significant disability, particularly hip fractures in older adults.
Osteoporosis itself causes no pain or symptoms in its early stages. Symptoms typically only become apparent once a fracture has occurred or significant bone loss has developed:
Because symptoms are absent until significant damage has occurred, screening and early detection are essential for people with risk factors.
Bone density peaks in early adulthood and naturally declines with age. Osteoporosis occurs when this decline is accelerated or when peak bone mass was never adequate. Key risk factors include:
Bone density is measured using a DEXA scan (dual-energy X-ray absorptiometry), a low-dose X-ray that measures bone mineral density (BMD) at the hip and spine. Results are reported as a T-score:
The FRAX tool (Fracture Risk Assessment Tool) is also used to calculate a person's 10-year probability of major osteoporotic fracture, combining BMD with other clinical risk factors.
Blood and urine tests may be ordered to rule out secondary causes of bone loss (such as vitamin D deficiency, thyroid disease, or malabsorption). A Medicare rebate for DEXA scanning is available for people who meet certain eligibility criteria, such as women aged 70 or over, people on long-term corticosteroids, or those with a history of fracture.
Treatment aims to slow bone loss, maintain bone density, and reduce fracture risk through a combination of lifestyle measures and medication.
Lifestyle measures
Adequate calcium intake (approximately 1,300 mg/day for women over 50 and men over 70) through diet or supplementation, and vitamin D for calcium absorption, form the foundation of management.
Weight-bearing exercise such as walking and resistance training helps maintain bone density. Falls prevention — including home hazard assessment, balance exercises, and medication review — is also important.
Bisphosphonates are the most widely used first-line treatment, available as weekly or monthly oral tablets or an annual intravenous infusion (zoledronic acid).
The following specialty medications that may be available at Ace, a specialty pharmacy for Osteoporosis.
Note: Calcium and vitamin D supplements are essential to osteoporosis management but are available over-the-counter and are not listed here as specialty medications.
With Ace, you’ll benefit from:
Take control of your health and well-being, and start your journey to better health with Ace today.